These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3003067

  • 1. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP, Borsotto M, Barhanin J, Fosset M, Lazdunski M.
    J Biol Chem; 1986 Jan 25; 261(3):1393-7. PubMed ID: 3003067
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP, Fosset M, Lazdunski M.
    Biochem Biophys Res Commun; 1985 Oct 15; 132(1):49-55. PubMed ID: 2998366
    [Abstract] [Full Text] [Related]

  • 3. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M, Barhanin J, Borsotto M, Fosset M, Galizzi JP, Renaud JF, Romey G, Schmid A.
    J Cardiovasc Pharmacol; 1986 Oct 15; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [Abstract] [Full Text] [Related]

  • 4. A novel high affinity class of Ca2+ channel blockers.
    Qar J, Barhanin J, Romey G, Henning R, Lerch U, Oekonomopulos R, Urbach H, Lazdunski M.
    Mol Pharmacol; 1988 Apr 15; 33(4):363-9. PubMed ID: 2965787
    [Abstract] [Full Text] [Related]

  • 5. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ, Snowman AM, Snyder SH.
    J Pharmacol Exp Ther; 1986 Jun 15; 237(3):731-8. PubMed ID: 3012067
    [Abstract] [Full Text] [Related]

  • 6. Molecular approach to the calcium channel.
    Glossmann H, Ferry DR, Goll A, Linn T.
    Adv Myocardiol; 1985 Jun 15; 5():41-76. PubMed ID: 2578683
    [Abstract] [Full Text] [Related]

  • 7. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H.
    FEBS Lett; 1984 Oct 29; 176(2):371-7. PubMed ID: 6092142
    [Abstract] [Full Text] [Related]

  • 8. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R, Knaus HG, Glossmann H.
    J Biol Chem; 1991 Jun 15; 266(17):10787-95. PubMed ID: 1645709
    [Abstract] [Full Text] [Related]

  • 9. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL, Johnson CL, Schwartz A.
    Mol Pharmacol; 1987 Feb 15; 31(2):175-9. PubMed ID: 2433570
    [Abstract] [Full Text] [Related]

  • 10. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M.
    J Cardiovasc Pharmacol; 1985 Feb 15; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [Abstract] [Full Text] [Related]

  • 11. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
    Galizzi JP, Fosset M, Lazdunski M.
    Eur J Biochem; 1984 Oct 15; 144(2):211-5. PubMed ID: 6092067
    [Abstract] [Full Text] [Related]

  • 12. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ, Tuana BS.
    Can J Physiol Pharmacol; 1990 Nov 15; 68(11):1389-95. PubMed ID: 1962734
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P, Flockerzi V, von Nettelbladt E, Oeken J, Hofmann F.
    Eur J Biochem; 1985 Jul 15; 150(2):313-22. PubMed ID: 2990931
    [Abstract] [Full Text] [Related]

  • 16. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ, Rogers CA, Sunahara RK, Lemaire S, Tuana BS.
    Mol Pharmacol; 1990 Feb 15; 37(2):173-81. PubMed ID: 2154669
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U, Pongs O.
    Eur J Biochem; 1989 May 01; 181(2):467-73. PubMed ID: 2540975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
    Borsotto M, Barhanin J, Norman RI, Lazdunski M.
    Biochem Biophys Res Commun; 1984 Aug 16; 122(3):1357-66. PubMed ID: 6089781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.